~~<i id='1BB30774C0'><strike id='1BB30774C0'><tt id='1BB30774C0'><pre id='1BB30774C0'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

knowledge

author：leisure time 2025-09-27 16:47:19 - browse：85

WASHINGTON — Back in 1980, when the Food and Drug Administration approved the use of lead acetate in hair dyes, little was known about the way skin absorbs toxic chemicals.

The skin — and the scalp in particular — were considered tough barriers to break, and many public health officials believed that even if small amounts of lead got through, or were inhaled, it couldn’t really hurt anyone.

But in science, 37 years is an eon. So a coalition of environmental groups, academics, and consumer advocates is pushing FDA to take lead acetate off the market. It is now permitted as a color additive.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Grail spinoff by Illumina should end disastrous merger attempt

hotspot

leisure time

hotspot

Wikipedia

hotspot

AdobeThere’sampleevidencethatprivateequitybuyoutsinhealthcaredriveupcosts.Anewstudyshowsqualitydecli

WSS

How to save health care price transparency rules

HHS secretary Becerra pressed on Change HealthCare cyberattack

John Green on his newest strategy for fighting tuberculosis

Male and female sex labels in research insufficient, scientists say

What STAT readers think about the FDA and patient advocacy

Christmas in the PICU brings some surprising joy

focus

knowledge

hotspot

Bright Health sells Medicare Advantage business to Molina

Amid AI frenzy, a top HHS official's quest to create safeguards

George Santos makes 1st court appearance after pleading not guilty to 13 counts

David Ricks of Eli Lilly: best biopharma CEO of 2023

The high cost of giving birth even with insurance

Readout Newsletter: The latest on Moderna, Apellis, and Merck

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

Bright Health sells Medicare Advantage business to Molina

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

leisure time

Medicare coverage of Wegovy, once blocked, now looks possible

Albert Bourla of Pfizer: worst biopharma CEO of 2023

Boston's new lab space is opening empty

How to save health care price transparency rules

Why depression after traumatic brain injury is distinct

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

leisure time

hotspot

Wikipedia

hotspot